The Latest in Pharmacy

Committee votes against rivaroxaban for ACS

January 18, 2014

FDA committee votes in favor of vorapaxar

January 17, 2014

Survey quantifies impact of drug shortages

January 10, 2014

Pharmacy

Out-of-pocket costs hinder adherence to imatinib

January 8, 2014

NICE recommends pixantrone for NHL

January 7, 2014

FDA approves ibrutinib for previously treated MCL

November 14, 2013

Fraud, errors were behind delay of apixaban approval, report shows

July 10, 2013

Company suspends enrollment in drug trials

February 21, 2013

FDA approves pomalidomide for MM

February 12, 2013

FDA approves drugs faster than EMA, Health Canada

May 18, 2012

Eculizumab gets accelerated approval for aHUS

September 23, 2011